Table 3.
Study | CVR in relation to SVD features | CVR in subjects vs. controls | CVR in relation to other features | Safety and tolerability |
---|---|---|---|---|
Gauthier et al.15 Total n = 85 | WMH volume not associated with frontal lobe CVR | Frontal lobe CVR 0.22 ± 0.06%/mm Hg in subjects vs. 0.25 ± 0.08%/mm Hg in young controls | CVR decreased with age | 2 patients excluded due to discomfort when breathing via Respiract™ device |
Richiardi et al.16 Total n = 63 | No association between ‘CVR velocity’ and Fazekas score | Mean time to reach 90% of peak BOLD response 59 s for MCI and AD patients vs. 33 s for controls | ‘CVR velocity’ increased with increasing MMSE score | No discomfort reported |
Conijn et al.17 Total n = 49 | Microbleeds associated with decrease in CVR. No CVR association with lacunes or WMH severity | Not applicable | CVR decreased with increasing age, female gender and increasing diastolic blood pressure | Not assessed |
Yezhuvath et al.18 Total n = 25 | Decreased CVR associated with increased WMH volume | CVR decreased in frontal lobe, insula and anterior cingulate gyrus in subjects compared to controls | Decreased CVR associated with a lower Boston Naming Score | 5 subjects and 4 controls declined to take part in CVR scan but no reasons given |
Hund-Georgiadis et al.19 Total n = 17 | Increased severity of SVD features (composite score of WMH, lacunes and enlarged perivascular spaces) associated with decreased CVR | Subjects had lower whole brain CVR than older controls, who in turn had lower CVR than young controls. Subjects had reduced CVR in frontal and parietal cortex vs. both control groups and in occipital cortex vs. young controls | CVR decreased with age | Not assessed |
AD: Alzheimer’s disease, MCI: mild cognitive impairment, MMSE: Mini Mental State Examination.